Global /United States /Healthcare /Medical Devices /SYK
chevron_leftBack

Stryker Corp.

SYK
NYSE: SYK Delayed
357.11USD 2.6%
As of 24 April 2025, Stryker Corp. has a market cap of $136.3B USD, ranking #110 globally and #67 in the United States. It ranks #16 in the Healthcare sector, and #3 in the Medical Devices industry.
Global Rank
110
Country Rank
67
Sector Rank
16
Industry Rank
3
Key Stats
Market Cap
$136.3BUSD
Enterprise Value
$145.93BUSD
Revenue (TTM)
$22.6BUSD
EBITDA (TTM)
$6.01BUSD
Net Income (TTM)
$2.99BUSD
EBITDA Margin
27%
Profit Margin
13%
PE Ratio
46.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Kevin Lobo open_in_new
Employees
53,000
Founded
1941
Website
stryker.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2.6% 3% -3.8% -8.5% -2.4% 9%
Upcoming Earnings
Earnings Date
Thu, May 1
Earnings Time
bedtime After Close
EPS Estimate
$2.86 14% yoy
Revenue Estimate
$5.7B 8.7% yoy

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
SYK
Stryker Corp
ISIN: US8636671013
Shares Out.:
381.689M1 Shares Float: 357.092M2
TV:
SA:
YF:
SYK
GF:
NQ:
SYK
BA:
SYK
MS:
357.11 USD
London Stock Exchange
MIC: XLON
0R2S
Stryker Corp
ISIN: US8636671013
TV:
SA:
YF:
GF:
BA:
MS:
349.25 USD
Borsa Italiana
MIC: XMIL
1SYK
Stryker Corp
ISIN: US8636671013
TV:
SA:
YF:
GF:
BA:
MS:
306.90 EUR
Mexican Bolsa
MIC: XMEX
SYK
Stryker Corp
ISIN: US8636671013
TV:
SA:
YF:
GF:
BA:
SYK
MS:
6.83K MXN
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Stryker Corp.

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
Abbott Laboratories
ABT
$225.15B
65%
Boston Scientific Corp.
BSX
$146.24B
7.3%
Edwards Lifesciences Corp.
EW
$41.27B
-70%
DexCom, Inc.
DXCM
$26.37B
-81%
Zimmer Biomet Holdings, Inc.
ZBH
$19.81B
-85%
Industry: Medical Devices (Global)
Name
Market Cap diff.
Medtronic plc
MDT
$107.37B
-21%
Siemens Healthineers AG
SHL
$57.76B
50.97B EUR
-58%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
$36.05B
262.7B CNY
-74%
Koninklijke Philips N.V.
PHIA
$22.18B
19.57B EUR
-84%
STERIS plc
STE
$22.0B
-84%